Long-term (+52 weeks) randomized controlled trial of anti-depressants shows that they're safe and effective
One-OffSalud y medicina3aManifold MarketsSin KYCDatos de resolución verificadosCalibración aceptablePronóstico comunitario actualSí 68.8%
Pronosticadores
7
Tipo de pregunta
binary
Metodología
Play-money forecasting platform
Tipo de fuente
Pronóstico
Datos de mercado
Actualizado hace 22 horas
Desactualizado6 mar 25, 19:37 UTC14 mar 30, 10:59 UTC
Tendencias
Reglas
Randomized placebo-controlled studies of antidepressants are under 52 weeks, yet the median use of antidepressants is 5 years.
- This market predicts whether the next eligible trial of antidepressants shows that they are safe and effective over 52 weeks duration
- Definitions:
- eligible trial - placebo-controlled randomized controlled trial over 52 weeks that measures both efficacy and safety
- effective - beats placebo control
- safe - risks and side effects are not found to be worse than currently known
